0001104659-24-073634.txt : 20240620
0001104659-24-073634.hdr.sgml : 20240620
20240620214110
ACCESSION NUMBER: 0001104659-24-073634
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240618
FILED AS OF DATE: 20240620
DATE AS OF CHANGE: 20240620
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bedrosian Camille L
CENTRAL INDEX KEY: 0001326969
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38223
FILM NUMBER: 241058241
MAIL ADDRESS:
STREET 1: C/O ULTRAGENYX PHARMACEUTICAL INC.
STREET 2: 60 LEVERONI COURT
CITY: NOVATO
STATE: CA
ZIP: 94949
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: RHYTHM PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001649904
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 462159271
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 222 BERKELEY STREET
STREET 2: 12TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 857-264-4280
MAIL ADDRESS:
STREET 1: 222 BERKELEY STREET
STREET 2: 12TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
FORMER COMPANY:
FORMER CONFORMED NAME: RHYTHM METABOLIC, INC.
DATE OF NAME CHANGE: 20150803
4
1
tm2417588-3_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-06-18
0
0001649904
RHYTHM PHARMACEUTICALS, INC.
RYTM
0001326969
Bedrosian Camille L
222 BERKELEY STREET, 12TH FLOOR
BOSTON
MA
02116
1
0
0
0
0
Stock Option (right to buy)
41.39
2024-06-18
4
A
0
14000
0
A
2034-06-17
Common Stock
14000
14000
D
Restricted Stock Units
2024-06-18
4
A
0
4000
0
A
Common Stock
4000
4000
D
The options fully vest upon the earlier of (i) June 18, 2025 or (ii) the date of the Issuer's annual meeting of the stockholders to be held in 2025, subject to the Reporting Person's continued service on such vesting date.
Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
The restricted stock units fully vest upon the earlier of (i) June 18, 2025 or (ii) the date of the Issuer's annual meeting of the stockholders to be held in 2025, subject to the Reporting Person's continued service on such vesting date. The restricted stock units have no expiration date.
/s/ Hunter Smith, attorney-in-fact for Camille L. Bedrosian
2024-06-20